HomeFRX • TSE
add
Fennec Pharmaceuticals Inc
Previous close
$6.70
Day range
$7.02 - $7.13
Year range
$6.70 - $15.43
Market cap
198.39M CAD
Avg Volume
705.00
P/E ratio
134.05
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 7.26M | 118.41% |
Operating expense | 11.69M | 49.09% |
Net income | -5.55M | -2.00% |
Net profit margin | -76.47 | 53.30% |
Earnings per share | -0.20 | 4.76% |
EBITDA | -5.01M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 43.05M | 187.83% |
Total assets | 63.16M | 224.95% |
Total liabilities | 64.52M | 121.22% |
Total equity | -1.36M | — |
Shares outstanding | 27.36M | — |
Price to book | -134.00 | — |
Return on assets | -19.04% | — |
Return on capital | -38.87% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -5.55M | -2.00% |
Cash from operations | -8.39M | -112.54% |
Cash from investing | — | — |
Cash from financing | 257.00K | -50.00% |
Net change in cash | -8.13M | -136.89% |
Free cash flow | -7.06M | -220.04% |
About
Founded
1996
Headquarters
Website
Employees
29
